Intra-amniotic LPS and cytokines may decrease respiratory distress syndrome (RDS) and increase chronic lung disease in the newborn. The aim was to identify the primary inflammatory mediators regulating the expression of surfactant proteins (SP) i n explants from immature (22-d-old fetus) and mature (30-d term fetus and 2-d newborn) rabbit. In immature lung, IL -1α and IL -1β upregulated the expression of SP-A and SP-B. These effects of IL-1 were diminished and SP-C mRNA was additively suppressed in t he presence of TNF-α and either LPS or IFN-γ. LPS, TNF-α or IFN-γ had no effect alone. In explants from the term fetus and the newborn, LPS, IL-1α and TNF-α additively suppressed the SPs. LPS acutely induced IL -1α in alveolar macrophages in mature lung, but not in the immature lung. IFN-γ that generally has low expression in intrauterine infection, decreased the age-dependence of the other agonists' effects on SPs. Present study serves to explain the variation of the pulmonary outcome following an inflammatory insult. We propose that IL -1 from extrapulmonary source induces the surfactant proteins in premature lung and is responsible for the decreased risk of RDS in intra-amniotic infection.
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Introduction
Deficiency in pulmonary surfactant is the main cause of respiratory distress syndrome in the newborn (RDS) (11) . Apart from specific phospholipids, the complex consists of surfactant-specific proteins that are important, if not essential for its function (22) . Surfactant protein A (SP-A) binds to surfactant phospholipids and thereby improves surface activity in vitro (4, 48) . By binding to specific microbes and alveolar macrophages, it also facilitates the phagocytosis of these microbes (13) . The functions of SP-B relate to intracellular processing of the surfactant components eg normal processing of SP-C (58) and to the surface tension-reducing function of the complex (42, 61) . SP-C has important roles in the formation and maintenance of the surfactant monolayer (34) .
The variety of hormones, growth factors, cytokines and other agents influence the differentiation and metabolism of the surfactant complex. Glucocorticoid is extensively studied for its roles in the regulation of surfactant proteins (40) . The proinflammatory cytokines IL -1 and TNF-α, which are induced in macrophages as a result of exposure to microbial products, influence the expression of surfactant proteins. TNF-α inhibits SP-A and SP-B and decreases SP-A and SP-B mRNA in human pulmonary adenocarcinoma cells (60, 63) . TNF-α also downregulates SP-C mRNA after intratracheal administration to adult mice and inhibits SP-C gene transcription in vitro (1) . IL -1α enhances the expression of SP-A mRNA in fetal rabbit lung explants in vitro (14) . The IL -1-induced effect on the expression of SP mRNA and proteins in vitro was dependent on lung maturity. In immature lung IL -1α upregulated SP-A and SP-B, while in mature lung it downregulated SP-B and SP-C (19) . IFN-γ influenced SP-A content in human pulmonary adenocarcinoma cells (63) 2 and SP-A expression in human fetal lung explants, whereas the expression of SP-B and SP-C were unaffected (2) .
Intratracheal aerolization or injection of LPS into adult rats increases the production of TNF-α (38, 55, 56) and IL -1 mRNA in the lung (55) . IFN-γ is induced by LPS in monocytes and lymphocytes (35) , whereas IFN-γ augments LPS-induced TNF-α production in monocyte/macrophages, including in alveolar macrophages (62, 64) . On the other hand IFN-γ did not enhance LPS-induced upregulation of IL-1 mRNA (64) . The interactions between IL -1 and TNF-α and their capacity to induce and suppress a variety of other cytokines (28, 51, 54) have been extensively studied and are known to possess synergistic or additive effects on many functions (15, 17) .
Responsiveness to microbes has been shown to be deficient in pulmonary macrophages from an early age (49) , which is a possible cause of an increased susceptibility to infections, neonatal pneumonia in particular. Infants born very premature due to chorioamnionitis, show a decreased incidence of RDS and an increased incidence of chronic lung disease (CLD) (59) . On the other hand, in intraamniotic infections, the concentrations of IL-1 (44) and TNF (45) are increased in amniotic fluid (AF) and in lung effluent after premature birth. In infants developing CLD, several proinflammatory cytokines and chemokines are increased in the airways, whereas the levels of certain anti-inflammatory cytokines may be decreased (31, 52) .
In the present study, we hypothesized that the complex association between the antenatal placental inflammatory disease and the incidence of pulmonary disease in the newborn is in part due to differences in responsiveness to microbial toxins and cytokines between undifferentiated ("immature") and differentiated ("mature") pulmonary alveolar epithelium. We studied the age-dependence of the LPS effect on Organ culture. The large airways were removed and the lungs were cut into cubes of approximately two mm 3 using sterile scissors. Five pieces were placed in a culture dish on a filter paper placed on a metallic grid. The tissue pieces were partly in contact with the atmosphere, partly with the culture medium. Waymouth's serumfree medium MD 705/1 (Gibco, Paisley, Scotland) containing penicillin (100 U/ml), streptomycin (100 µg/ml), fungizone (0.25 µg/ml) and glutamine (2 mM) was used in a humidified atmosphere containing 5% CO 2 and 95% air. The lung explants were cultured in the presence of LPS, IL-1α, TNF-α, IFN-γ, different combinations of was also seen after 12 hours and did not change after prolonged incubation (data not shown). Different concentrations were also used for IL -1α (19) , LPS (10-1000 ng/ml) and TNF -α (10-100 ng/ml), (data not shown). The most informative data is shown here. After the culture the explants were harvested into liquid nitrogen and stored at -70°C until used for mRNA or protein analysis. When indicated, the explants were fixed with 4% neutral formaldehyde for immunohistochemistry.
Analysis of mRNA. Total RNA was isolated and SP-A, -B and -C mRNAs
were quantified using Northern blot analysis, as described previously (19) . 
Immunohistochemistry of IL-1α.
Western Blot Analysis of SP-B.
Proteins from the explants were isolated essentially according to Clark et al (10) . The lung explants were homogenized in 10 was analyzed using Student's t test for non-paired data. When indicated, one-way analysis of variance (ANOVA) followed by post hoc analysis using the Fisher test was performed. A P value of < 0.05 was considered as significant.
Results
LPS and cytokine effects on SP mRNA. LPS at two different concentrations (100 ng/ml and 1 µg/ml) did not significantly affect the SP-A, -B or -C expression in lung explants from 22-day-old fetal rabbits. In LPS-treated explants from 30-day-old fetal and 2 day-old newborn rabbits, SP-B and SP-C mRNAs were suppressed in a concentration-dependent manner. SP-A mRNA was suppressed only at 1 µg/ml IFN-γ at 10 ng/ml or 100 ng/ml had little, if any detectable effect on surfactant protein expression at any age (Table 1) . However, IFN-γ added in combination with LPS (100 ng/ml) suppressed SP-B and SP-C mRNAs in explants from 22-day-old 8 fetuses. In explants from 30-day-old fetal rabbits, IFN-γ (100 ng/ml) tended to potentiate the LPS-induced downregulation of SP-B and SP-C mRNAs, and the effect on SP-C was significant when IFN-γ was added together with LPS at 100 ng/ml (P = 0.02). In contrast, in explants from 2-day-old newborn rabbits, IFN-γ (100 ng/ml) tended to decrease the suppressive effect of LPS (1 µg/ml) on SP expression.
In explants from 22-day-old fetuses, the addition of IL -1α and TNFα together with LPS had a different effect on SP mRNA expression compared to the cytokines 
Expression of IL-1α.
In lung explants from 30-day-old fetuses and 2-day-old newborns, LPS increased the immunoreactivity of IL-1α in future airspaces. In lung explants from 22-day-old fetuses, after the addition of LPS, there was some IL -1 immunoreactivity associated with macrophages from pleura and interstitium (data not shown), but no immunoreactivity was evident in airspaces ( Figure 5 ). There was no detectable IL -1 in amniotic fluid in normal human pregnancy and only a small increase in IL -1 levels in term labor (44) , whereas IL -1 receptor antagonist (IL-1ra) levels have been reported to be high (8, 46) . Since, additionally intra-amniotic IL -1ra failed to suppress the expression of surfactant proteins, IL -1 appears to serve as a salvage pathway rather than obligatory signaling of lung maturation (7) . In premature labor due to intrauterine infection (IUI), the concentrations of IL-1 and TNF-α increase in the amniotic fluid towards levels used in the present in vitro study (44, 45) . However the concentrations of LPS in the amniotic fluid were generally two orders magnitude lower than those of IL-1α, IL -β or TNF-α (20) . This is consistent with the hypothesis that cytokines accelerate maturation of fetal lung. Within 2-4 h after the addition of IL -1α to lung explants from 19-to 22-dayold rabbit fetuses, IL-1 increased the expression of SP-A and SP-B (14, 19) . This acute IL -1 effect was not affected when the explants were pre-incubated in the presence of indomethacin, prostaglandin-E 2 or dibutyryl cAMP (data not shown).
However, in the immature lung LPS neither influenced the expression of SPs nor induced IL-1α in the terminal air spaces. On the basis of current evidence, we propose that, in intrauterine infection or following intra-amniotic injection of LPS (6, 30) , the generation of IL-1 and as yet undefined downstream mediators are responsible for the increase in the expression of surfactant proteins (7, 18, 19) and for the decrease in the incidence of RDS (59) . The lack of IL -1α induction in the airways after the addition of LPS to immature lung in vitro implies that extra-alveolar macrophages mediate the acceleration of fetal lung maturation. Macrophages from the fetal membranes are a likely source of cytokines since they produce IL -1 as a response to LPS (47) and the fetal breathing movements enable the contact of amniotic fluid with the future respiratory tract (24) .
Toll-like type-1 transmembrane receptor 4 (TLR4) together with MD2 and CD14 mediate the LPS signal that leads to the activation of transcription factor NF-κB (9, 27, 50) . TLR4 may also activate the stress-activated protein kinase (SAPK)/c-Jun (Fig 3) . The latter includes IFN-γ that, however, has been found to have low expression levels in fetal and placental tissues (41) .
The downregulation of SP mRNAs by the proinflammatory cytokines and LPS may play an important role in the pathogenesis of life-threatening respiratory failure.
As shown here and by others (19, 63) , cytokine -induced changes in SP mRNA are reflected in the levels of the proteins. In small premature infants developing CLD (31, 52, 59) , and in acute respiratory syndrome (ARDS) (29) , the proinflammatory cytokines are increased in the airways. The surfactant defects evident in CLD and in 
Figure 3
Effects of the combinations of LPS (100 ng/ml or 1 µg/ml) and IFN-γ (100 ng/ml); LPS (1 µg/ml), IL-1α (57 ng/ml) and TNF-α (100 ng/ml); IL -1α (57 ng/ml), TNF -α (100 ng/ml) and IFN-γ (10 ng/ml or 100 ng/ml) on the SP-A, -B and -C mRNA expression in lung explants from 22 (n = 4-12) and 30 fetal days (n = 8-14) and from 2-day-old newborn (n = 8-12). Incubation time was 12 hours and the bars show the SP Detection of SP-B on Western Blots. Lung explants from 30-day-old fetuses were cultured for 20 hours in the presence of vehicle (C), rhIL-1α 57 ng/ml (IL-1), rhTNF-α 100 ng/ml (TNF) or combination of IL-1α 57 ng/ml and TNF-α 100 ng/ml (IL -1+TNF). SP-B was suppressed by TNF-α and by the combination of IL -1α and TNF-α. Table 1 . Footnotes
The SP-A, SP-B and SP-C mRNA levels are presented as mean ± SEM on the basis of the vehicle -treated controls. IFN-γ had no effect on SP expression in the lung explants from rabbit fetuses or newborns.
